You just read:

Research and Markets - Global T-Cell Immunotherapy Pipeline Analysis 2016-2017: Novartis, Kite Pharma, Juno Therapeutics, and Sorrent Therapeutics are Actively Involved

News provided by

Research and Markets

10 Mar, 2017, 11:15 ET